Skip to content

Talphera, Inc. TLPH Gross Profit

Discontinued — last reported Q4 '22

Gross Profit at other companies

Baxter International logo
Baxter InternationalBAX
$891M+3.5%
AMP
Amphastar PharmaceuticalsAMPH
$70.32M-17.5%
PTH
Pelthos Therapeutics Inc.PTHS
$9.23M
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$54.21M+10.8%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$34.32M+80.1%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS

Other financials

Income statement

See full
Revenue--100%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+493%
P/S53,456.6×+53,123×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Calculated from Talphera, Inc.’s reported figures.

The official record: Talphera, Inc.’s 10-K, filed March 6, 2024, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s gross profit?
Talphera, Inc. (TLPH) reported gross profit of -$1.88M in Q4 2022.
How has Talphera, Inc.'s gross profit changed year-over-year?
Talphera, Inc.'s gross profit decreased by 52.7% year-over-year, from -$1.23M to -$1.88M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.